Five Prime Therapeutics, Inc. Operating Lease Liability
Five Prime Therapeutics, Inc. had Operating Lease Liability of $47.59 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2020-08-06
- 2020-06-30: Operating Lease, Liability $47.59M.
- 2020-03-31: Operating Lease, Liability $48.63M.
- 2019-12-31: Operating Lease, Liability $49.61M.
- 2019-09-30: Operating Lease, Liability $50.52M.
| Period end | Operating Lease, Liability |
|---|---|
| 2020-06-30 | $47.59M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $48.63M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $49.61M 10-K · filed 2020-02-27 |
| 2019-09-30 | $50.52M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $51.43M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $52.30M 10-Q · filed 2019-05-09 |